The CLDN6 gene helps make a protein that forms tight seals between neighboring cells, mainly during early development. This helps tissues develop in an organized way and supports barrier function. If the gene does not work normally, cells may not seal together as they should, which can affect how tissues form. In most adult tissues, the gene is usually quiet, but unusual CLDN6 activity has been found in some cancers, where it may play a role in tumor behavior.
What is a gene?
A gene is a stretch of DNA that holds instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, the parts of cells that do much of the work. Others mainly help govern when certain processes happen, where they happen, and how strongly they run. Together, genes affect how the body develops and works, and they can influence how you respond to food, stress, and medications. For a deeper look at this topic, more information is available in the LearnHub.
Overview
CLDN6Gene function
What if the gene works
The CLDN6 gene helps make claudin-6, a protein that helps form seals between neighboring cells. It is most active during early development, where it supports organized tissue growth and cell barriers.
Risk
What if the gene does not work
Variants in the CLDN6 gene can range from milder to more severe and may reduce how well cells form tight, selective seals with neighboring cells. This can weaken barrier control and alter cell to cell signaling during early tissue development.
Treatment
What does that mean for your treatment
At present, no treatment or management approach tied to a pathogenic or loss-of-function variant in the CLDN6 gene is currently established. CLDN6 is being studied mainly as a cancer biomarker and treatment target in tumors that express it, rather than as a guide for treating inherited CLDN6 variants.
Gene function
What if the gene works
Neighboring cells need neat, controlled seals to build healthy tissues. The CLDN6 gene helps make those seals, especially during early development, by adding a key part of tight junctions, the barriers between nearby cells. This helps explain what the CLDN6 gene does in the body as cell layers form and organize.
The CLDN6 gene provides part of the tight junctions that join neighboring cells. These junctions create close seals, helping cell layers stay connected and neatly arranged.
CLDN6 helps regulate what can pass through the tiny spaces between nearby cells. This supports a more selective barrier in cell layers that line body surfaces and developing organs.
Its protein helps cells keep clear boundaries and an inside and outside side. That organized layout supports normal tissue patterning, especially as early body structures take shape.
What is a variant?
Within a gene, a genetic variant is a small difference in its DNA sequence. These differences are common and help shape normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental influences. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can more substantially change how a gene functions and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Changes in the CLDN6 gene can alter how much CLDN6 protein a cell makes, how well it folds, and whether it reaches the cell membrane to assemble at contact points between neighboring cells. Milder variants may only partly reduce stability or membrane placement, while more disruptive variants can shorten the protein or markedly weaken its interactions with partner proteins. This captures how CLDN6 gene variants affect protein function at the cellular level.
How variants are linked to conditions
At this time, the CLDN6 gene does not yet have a broadly confirmed link to a specific health condition, and research on CLDN6 gene variants linked to conditions is still developing. Anyone with a confirmed CLDN6-related finding should use their doctor’s or genetic counselor’s advice to understand what it may mean for their own health and family.
A variant is not necessarily a diagnosis
Genetic variants are common across people and are a usual part of human biology. Most do not directly affect health and simply contribute to normal human variation. For many genes, having a variant associated with a condition suggests a possible link rather than a certain diagnosis, especially when several genes and environmental influences are involved. In some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There isn't yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the CLDN6 gene. If CLDN6 appears on a test result, its meaning usually depends on the exact finding and the wider clinical picture, so discussing personal risk with a doctor or genetic counselor can help.
Inheritance of CLDN6 variants
Current evidence has not established a broadly confirmed disease inheritance pattern for CLDN6 gene variants in humans. In other words, CLDN6 gene inheritance is not tied to a well-defined autosomal dominant, autosomal recessive, or X-linked condition at this time. The CLDN6 gene is located on chromosome 16, which is an autosome, so each person inherits one copy from each parent.
What does my CLDN6 result mean for my family?
There isn't yet a broadly confirmed inheritance pattern tied to a specific health condition for CLDN6, though this can become clearer as research grows. If you have a specific CLDN6 result and want to understand what it could mean for relatives, a doctor or genetic counselor can explain it in the context of your family history and the exact finding.
Genetic information
Genetic testing
How you find out about variants
Doctors find variants in the CLDN6 gene through CLDN6 genetic testing, which reads DNA from a blood sample, saliva, or a cheek swab. Testing may look only at the CLDN6 gene or include it in a larger panel, and the report shows whether a variant was found and how clearly it is understood.
When should I consider getting a genetic test?
There isn't yet a broadly established, CLDN6-specific reason for genetic testing in routine care. Testing decisions are usually based on your personal health history, family history, and the broader question a doctor or genetic counselor is trying to answer.
A genetic result is only one part of your health story
A genetic finding can be helpful, but what it can tell you varies with the condition and the kind of variant involved. Lifestyle, environment, age, and medical history all shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best considered alongside other parts of care. In other situations, a genetic result can give a clear answer. In areas such as medication response, genetic findings can also help place individual experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body absorbs, breaks down, or reacts to a treatment, so the same medication may work well for one person but less well for another. This is a common part of human biology and can influence both how much benefit someone gets and how sensitive they are to side effects.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences shape a person’s response to medications. By studying links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence how strongly a drug works or how the body processes it. This information can support more informed, individualized treatment decisions. To explore this subject in greater detail, you can learn more in the LearnHub.
Drugs influenced by the CLDN6 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding how medicines are chosen or how well they work. If you have concerns about symptoms, treatment side effects, or how a medicine may affect you, it is best to talk with your doctor or pharmacist.
History
CLDN6 was identified in the late 1990s, during the period when researchers were defining the claudin family of proteins that help form the body’s tissue barriers. Initially understood only through visible traits, later recognized as tied to a specific gene, CLDN6 drew attention because it was active mainly in early development and far less active in most healthy adult tissues. That pattern made it useful in laboratory studies of how tissues form and mature. From these first observations, research expanded steadily into cancer biology, where CLDN6 was found to reappear in some tumors. This history has made the CLDN6 gene more important in research than in everyday public awareness.